Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases: where do we stand? (2020)
- Authors:
- USP affiliated authors: FARIAS, KELEN CRISTINA RIBEIRO MALMEGRIM DE - FCFRP ; RODRIGUES, MARIA CAROLINA DE OLIVEIRA - FMRP
- Unidades: FCFRP; FMRP
- DOI: 10.3389/978-2-88963-472-9
- Subjects: TRANSPLANTES; CÉLULAS-TRONCO; DOENÇAS AUTOIMUNES
- Language: Inglês
- Imprenta:
- Publisher: Frontiers Media
- Publisher place: Lausanne
- Date published: 2020
- ISBN: 9782889634729
- Status:
- Artigo possui versão em acesso aberto em repositório (Green Open Access)
- Versão do Documento:
- Versão publicada (Published version)
- Acessar versão aberta:
-
ABNT
Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases: where do we stand?. . Lausanne: Frontiers Media. Disponível em: https://doi.org/10.3389/978-2-88963-472-9. Acesso em: 31 mar. 2026. , 2020 -
APA
Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases: where do we stand? (2020). Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases: where do we stand? Lausanne: Frontiers Media. doi:10.3389/978-2-88963-472-9 -
NLM
Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases: where do we stand? [Internet]. 2020 ;[citado 2026 mar. 31 ] Available from: https://doi.org/10.3389/978-2-88963-472-9 -
Vancouver
Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases: where do we stand? [Internet]. 2020 ;[citado 2026 mar. 31 ] Available from: https://doi.org/10.3389/978-2-88963-472-9 - Editorial: immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases: where do we stand?
- New horizons in the treatment of type 1 diabetes: more intense immunosuppression and beta cell replacement
- Editorial: Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases [Editorial]: Where do we stand? Volume II
- Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases [Editorial]: where do we stand?
- Lower Insulin-Dose Adjusted A1c (IDAA1c) is associated with less complications in individuals with type 1 diabetes treated with hematopoetic stem-cell transplantation and conventional therapy
- Teplizumab in relatives at risk for type 1 diabetes. [Carta]
- New horizons in the treatment of type 1 diabetes: more intense immunosuppression and beta cell replacement
- Autologous hematopoietic stem cell transplantation for autoimmune diseases: from mechanistic insights to biomarkers
- CMV-specific clones may lead to reduced TCR diversity and relapse in systemic sclerosis patients treated with AHSCT [Carta]
- Monitoramento imunológico após transplante de células-tronco hematopoiéticas: identificação de biomarcadores de resposta ao tratamento
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
Por se tratar de integração com serviço externo, podem existir diferentes versões do trabalho (como preprints ou postprints), que podem diferir da versão publicada.
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
003032540.PDF |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
